Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹273 Cr₹293 Cr₹222 Cr₹192 Cr₹205 Cr

What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹273 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹273 Cr
Mar2025₹293 Cr
Mar2024₹222 Cr
Mar2023₹192 Cr
Mar2022₹205 Cr

How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2026 ₹273 Cr
-6.64
Mar2025 ₹293 Cr
31.75
Mar2024 ₹222 Cr
15.43
Mar2023 ₹192 Cr
-6.27
Mar2022 ₹205 Cr -

Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr -1.3% 0.2% -6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.3%

0.2%

-6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses